Kayoko Naiki

Iruma, 3500495, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Comprehensive genome analysis of hepatitis B virus using nanopore sequencing technology in patients with previously resolved infection and spontaneous reactivation without drug exposure.

Comprehensive genome analysis of hepatitis B virus using nanopore sequencing technology in patients with previously resolved infection and spontaneous reactivation without drug exposure.

Journal: Clinical journal of gastroenterology

Published: September 27, 2024

Serum zinc levels as predictors of covert hepatic encephalopathy in patients with liver cirrhosis.

Serum zinc levels as predictors of covert hepatic encephalopathy in patients with liver cirrhosis.

Journal: Journal of gastroenterology

Published: July 25, 2024

Switching from combination therapy with entecavir hydrate plus tenofovir alafenamide fumarate to tenofovir alafenamide fumarate monotherapy in patients with chronic hepatitis B based on nucleotide sequences of hepatitis B virus pregenome RNA.

Switching from combination therapy with entecavir hydrate plus tenofovir alafenamide fumarate to tenofovir alafenamide fumarate monotherapy in patients with chronic hepatitis B based on nucleotide sequences of hepatitis B virus pregenome RNA.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: December 11, 2023

Significance of portal venous blood flow as a factor to determine liver function in patients with decompensated cirrhosis due to hepatitis C virus infection following achievement of sustained viral response by sofosbuvir plus velpatasvir.

Significance of portal venous blood flow as a factor to determine liver function in patients with decompensated cirrhosis due to hepatitis C virus infection following achievement of sustained viral response by sofosbuvir plus velpatasvir.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: April 10, 2023

Significance of furosemide in patients with cirrhosis treated with or without zinc acetate hydrate supplementation.

Significance of furosemide in patients with cirrhosis treated with or without zinc acetate hydrate supplementation.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: December 08, 2021

Superiority of tenofovir alafenamide fumarate over entecavir for serum HBsAg level reduction in patients with chronic HBV infection: A 144-week outcome study after switching of the nucleos(t)ide analog.

Superiority of tenofovir alafenamide fumarate over entecavir for serum HBsAg level reduction in patients with chronic HBV infection: A 144-week outcome study after switching of the nucleos(t)ide analog.

Journal: PloS one

Published: September 09, 2021

Significance of switching of the nucleos(t)ide analog used to treat Japanese patients with chronic hepatitis B virus infection from entecavir to tenofovir alafenamide fumarate.

Significance of switching of the nucleos(t)ide analog used to treat Japanese patients with chronic hepatitis B virus infection from entecavir to tenofovir alafenamide fumarate.

Journal: Journal of medical virology

Published: July 18, 2020

Furosemide as a factor to deteriorate therapeutic efficacy of rifaximin in patients with decompensated cirrhosis.

Furosemide as a factor to deteriorate therapeutic efficacy of rifaximin in patients with decompensated cirrhosis.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: June 19, 2020

Furosemide as a factor to deteriorate therapeutic efficacy of tolvaptan in patients with decompensated cirrhosis.

Furosemide as a factor to deteriorate therapeutic efficacy of tolvaptan in patients with decompensated cirrhosis.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: June 19, 2020

Involvement of portosystemic shunts in impaired improvement of liver function after direct-acting antiviral therapies in cirrhotic patients with hepatitis C virus.

Involvement of portosystemic shunts in impaired improvement of liver function after direct-acting antiviral therapies in cirrhotic patients with hepatitis C virus.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: September 19, 2019

Significance of switching of the nucleos(t)ide analog used to treat Japanese patients with chronic hepatitis B virus infection from entecavir to tenofovir alafenamide fumarate.

Significance of switching of the nucleos(t)ide analog used to treat Japanese patients with chronic hepatitis B virus infection from entecavir to tenofovir alafenamide fumarate.

Journal: Journal of medical virology

Published: August 20, 2019

A case of genotype-3b hepatitis C virus in which the whole genome was successfully analyzed using third-generation nanopore sequencing.

A case of genotype-3b hepatitis C virus in which the whole genome was successfully analyzed using third-generation nanopore sequencing.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: January 14, 2019

Showing 1-12 of 24

Last Updated: 09/26/2026